GPKMEDIUM SIGNALFINANCIAL10-K

GPK's operating performance declined meaningfully while the company strengthened its balance sheet through reduced share buybacks and improved cash position.

The company experienced notable declines in both operating income and net income, coupled with higher interest expenses, suggesting either market headwinds or operational challenges. However, management appears to be taking a conservative approach by reducing capital returns to shareholders and building cash reserves, which could position the company for future opportunities or help weather current difficulties.

Comparing 2026-03-02 vs 2025-02-12View on EDGAR →
FINANCIAL ANALYSIS

GPK's operational performance weakened with both operating income and net income declining substantially year-over-year, while interest expenses increased notably to $239M. The company's balance sheet showed improvement with cash and equivalents growing substantially to $261M and stockholders' equity increasing to $3.3B, partly driven by reduced share buybacks of $150M versus $200M in the prior year. The overall picture suggests management is prioritizing financial flexibility over shareholder returns amid operational headwinds.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+66.2%
$157.0M→$261.0M

Cash position surged 66.2% — strong cash generation or capital raise providing significant financial cushion.

Net Income
P&L
-32.5%
$658.0M→$444.0M

Net income declined 32.5% — review whether driven by operations, interest costs, or non-recurring items.

Operating Income
P&L
-28.2%
$1.1B→$804.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Total Liabilities
Balance Sheet
-27%
$14.8M→$10.8M

Liabilities reduced 27% — deleveraging improves balance sheet strength and financial flexibility.

Share Buybacks
Cash Flow
-25%
$200.0M→$150.0M

Buyback activity reduced 25% — capital being redeployed elsewhere or cash conservation underway.

Interest Expense
P&L
+21.3%
$197.0M→$239.0M

Interest costs rose 21.3% — monitor debt levels and coverage ratio in rising rate environment.

Current Liabilities
Balance Sheet
+17.9%
$1.9B→$2.2B

Current liabilities rose 17.9% — increased short-term obligations, watch current ratio.

R&D Expense
P&L
+11.8%
$17.0M→$19.0M

R&D investment increased 11.8% — signals commitment to future product development, though near-term margin impact.

Stockholders Equity
Balance Sheet
+10.8%
$3.0B→$3.3B

Equity base grew 10.8% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-02
PRIOR — 2025-02-12
ADDED
See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
As of February 27, 2026 there were approximately 295,740,911 shares of the registrant's Common Stock, $0.01 par value per share outstanding.
M arket for R egistrant's C ommon E quity , R elated S tockholder M atters and I ssuer P urchase of E quity S ecurities 18 Item 6.
M anageme nt's D iscussion and A naly sis of F inancial C ondition and R esu lts of O perations 19 I tem 7 A.
C hanges in and Disagreements with Account ants on Accounting and Financial Disclosure 80 I tem 9 A .
+7 more — sign up free →
REMOVED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
As of February 11, 2025 there were approximately 300,214,465 shares of the registrant s Common Stock, $0.01 par value per share outstanding.
MARKET FOR REGISTRANT S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES 19 ITEM 6.
MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 21 ITEM 7 A.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 78 ITEM 9 A .
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →